117 related articles for article (PubMed ID: 8635061)
41. The prognostic significance of early stage lymph node positivity in operable invasive breast carcinoma: number or stage.
Rakha EA; Morgan D; Macmillan D
J Clin Pathol; 2012 Jul; 65(7):624-30. PubMed ID: 22523340
[TBL] [Abstract][Full Text] [Related]
42. Neglecting to screen women between 40 and 49 years old with mammography: what is the impact on treatment morbidity and potential risk reduction?
Plecha D; Salem N; Kremer M; Pham R; Downs-Holmes C; Sattar A; Lyons J
AJR Am J Roentgenol; 2014 Feb; 202(2):282-8. PubMed ID: 24450666
[TBL] [Abstract][Full Text] [Related]
43. To screen or not to screen: the issue of breast cancer screening in older women.
Caplan LS
Public Health Rev; 2001; 29(2-4):231-40. PubMed ID: 12418709
[TBL] [Abstract][Full Text] [Related]
44. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics.
Gajdos C; Tartter PI; Bleiweiss IJ; Hermann G; de Csepel J; Estabrook A; Rademaker AW
Ann Surg; 2002 Feb; 235(2):246-51. PubMed ID: 11807365
[TBL] [Abstract][Full Text] [Related]
45. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
[TBL] [Abstract][Full Text] [Related]
46. [Comparison of response evaluation methods of neoadjuvant chemotherapy in breast cancer patients].
Sun B; Song ST; Wu SK; Jiang ZF; Wang T; Zhang SH; Zhao YB; Yu CZ; Li XB; Yang T; Li GJ
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):783-5. PubMed ID: 20021835
[TBL] [Abstract][Full Text] [Related]
47. Treatment and survival of female patients with nonpalpable breast carcinoma.
Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
[TBL] [Abstract][Full Text] [Related]
48. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
49. [Detection of breast carcinoma: a statistical-epidemiological study of the current situation].
Schleicher UM
Rofo; 1995 Dec; 163(6):469-73. PubMed ID: 8547615
[TBL] [Abstract][Full Text] [Related]
50. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study.
Tarone RE
Cancer; 1995 Feb; 75(4):997-1003. PubMed ID: 7842421
[TBL] [Abstract][Full Text] [Related]
51. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
52. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.
Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Udvarhelyi N; Bak M; Kovács T; Mátrai Z
Eur J Surg Oncol; 2016 Dec; 42(12):1814-1820. PubMed ID: 27424787
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.
Tabar L; Fagerberg G; Chen HH; Duffy SW; Smart CR; Gad A; Smith RA
Cancer; 1995 May; 75(10):2507-17. PubMed ID: 7736395
[TBL] [Abstract][Full Text] [Related]
54. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
55. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.
Valente SA; Levine GM; Silverstein MJ; Rayhanabad JA; Weng-Grumley JG; Ji L; Holmes DR; Sposto R; Sener SF
Ann Surg Oncol; 2012 Jun; 19(6):1825-30. PubMed ID: 22227922
[TBL] [Abstract][Full Text] [Related]
56. [Long follow-up of breast cancer revealed by clustered microcalcifications without palpable mass].
Wehbe G; Sepanda M; Nos C; Falcou MC; Meunier M; Zafrani B; Fourquet A; Durand JC; Azoury J; Massoud E; Bentley Clough K
J Med Liban; 2004; 52(1):2-7. PubMed ID: 15881694
[TBL] [Abstract][Full Text] [Related]
57. Age-related differences in patients with nonpalpable breast carcinomas.
Wazer DE; Gage I; Homer MJ; Krosnick SH; Schmid C
Cancer; 1996 Oct; 78(7):1432-7. PubMed ID: 8839548
[TBL] [Abstract][Full Text] [Related]
58. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
59. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness.
Peer PG; Holland R; Hendriks JH; Mravunac M; Verbeek AL
J Natl Cancer Inst; 1994 Mar; 86(6):436-41. PubMed ID: 8120918
[TBL] [Abstract][Full Text] [Related]
60. Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older.
Freedman GM; Anderson PR; Goldstein LJ; Hanlon AL; Cianfrocca ME; Millenson MM; von Mehren M; Torosian MH; Boraas MC; Nicolaou N; Patchefsky AS; Evers K
Cancer; 2003 Sep; 98(5):918-25. PubMed ID: 12942557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
